Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
60.92 USD | -0.38% | -2.00% | +51.57% |
Financials (USD)
Sales 2024 * | 135M | Sales 2025 * | 181M | Capitalization | 2.38B |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -18M | EV / Sales 2024 * | 16.9 x |
Net cash position 2024 * | 101M | Net cash position 2025 * | 107M | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
-74.9
x | P/E ratio 2025 * |
-123
x | Employees | 374 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.84% |
Latest transcript on RxSight, Inc.
1 day | +0.92% | ||
1 week | -2.38% | ||
Current month | +17.30% | ||
1 month | +15.88% | ||
3 months | +5.58% | ||
6 months | +102.89% | ||
Current year | +51.66% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald Kurtz
CEO | Chief Executive Officer | 61 | 15-05-31 |
Shelley Thunen
DFI | Director of Finance/CFO | 71 | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Palmisano
BRD | Director/Board Member | 79 | 21-08-09 |
Bill Link
BRD | Director/Board Member | 78 | 16-10-31 |
Ronald Kurtz
CEO | Chief Executive Officer | 61 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +10.11% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 61.12 | -0.06% | 127 623 |
24-05-24 | 61.15 | +0.92% | 309,541 |
24-05-23 | 60.59 | -1.93% | 275,625 |
24-05-22 | 61.78 | -0.93% | 429,920 |
24-05-21 | 62.36 | -0.45% | 314,661 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.66% | 2.38B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- RXST Stock